Last week at the EuroCD-25, I talked about how the innovation landscape is changing in the cyclodextrin field.
What was dominated by pharma 20-30-40 years ago is getting taken over by non-pharma these days.
New derivatives (like polymers or conjugates) and innovative drug delivery solutions (like MOFs) emerge and get commercialized in cosmetic, environmental, household and nutraceutical uses.
My talk was not only describing the case studies but also analyzing what was the key to their success, what enabled them to be successful in the market.
In your opinion – what is the key for successful innovation?
